We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.42%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$23.5B
AUM Growth
+$825M
(+3.6%)
Cap. Flow
+$352M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
54.93%
Holding
76
New
13
Increased
23
Reduced
16
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$785M |
| 2 |
T-Mobile US
TMUS
|
+$463M |
| 3 |
Mastercard
MA
|
+$428M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$352M |
| 5 |
Microsoft
MSFT
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$678M |
| 2 |
Elevance Health
ELV
|
+$674M |
| 3 |
AET
Aetna Inc
AET
|
+$333M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$279M |
| 5 |
TransDigm Group
TDG
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 22.63% |
| 2 | Healthcare | 21.02% |
| 3 | Consumer Discretionary | 15.15% |
| 4 | Energy | 12.34% |
| 5 | Technology | 8.64% |
Similar funds
SAM
VIA
Viking Global Investors's Q2 2016 Portfolio in Review
As of Q2 2016, Viking Global Investors held 76 positions worth $23.5B, up 3.6% from $22.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Viking Global Investors's Q2 2016 filing shows 13 new, 23 increased, 16 reduced and 21 closed positions. Its largest new stake was Microsoft: 5,633,782 shares worth $288M. The largest sale was Allergan plc, an estimated $678M.
By sector, the portfolio is most concentrated in Communication Services at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Viking Global Investors's largest Q2 2016 buy was Microsoft: 5,633,782 shares worth $288M.
- Viking Global Investors added most to Biogen in Q2 2016, an estimated $785M increase.
- Viking Global Investors's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $678M.
- Viking Global Investors fully exited Elevance Health in Q2 2016, selling an estimated $674M.
- Viking Global Investors's ten largest holdings make up 55% of its $23.5B portfolio in Q2 2016.
- Viking Global Investors opened 13 new positions and closed 21 in Q2 2016.
- Viking Global Investors's portfolio value rose 3.6% quarter-over-quarter to $23.5B.
Based on Viking Global Investors's 13F filing for Q2 2016, filed 15 Aug 2016.